Celltrion, Inc. agreed to acquire a 64.46% stake in Celltrion Healthcare Co., Ltd. (KOSDAQ:A091990) for KRW 6.7 trillion on August 17, 2023. The merger will consist of the issuance of new shares of Celltrion stock to Celltrion Healthcare shareholders. The merger plan needs to be approved at a shareholders' meeting on October 23, 2023. Upon completion of the merger, the combined company will be called Celltrion and Celltrion Healthcare will be dissolved. The merger date is December 28 ,2023. The transaction is approved by shareholders of Celltrion, Inc. and Celltrion Healthcare Co., Ltd. Morgan Stanley (NYSE:MS) acted as financial advisor to Celltrion, Inc.

Celltrion, Inc. completed the acquisition of a 64.46% stake in Celltrion Healthcare Co., Ltd. (KOSDAQ:A091990) on December 28, 2023.